Online first
Case report
Published online: 2024-08-08

open access

Page views 23
Article views/downloads 10
Get Citation

Connect on Social Media

Connect on Social Media

Insights into an uncommon case: axillary extramammary Paget’s disease and TP53 mutation

Julia Zawistowska1, Leszek Kozłowski2, Katarzyna Pochodowicz3, Karolina Rogowska3, Angelina Lęgas4, Joanna Smalira3, Weronika Rogala3, Bartosz Przybysz5, Jakub Kawalec6, Weronika Rutkowska-Kawalec7

Abstract

Extramammary Paget’s disease (EMPD) is a rare malignancy primarily affecting areas rich in apocrine glands, such as the genitalia, perianal region, and axilla. Here is presented a case report of a 43-year-old woman with an unusual manifestation of EMPD in the axillary region, complicated by a history of multiple primary malignancies and a TP53 mutation. The patient’s oncological history includes two separate occurrences of breast cancer along with papillary thyroid carcinoma. Genetic testing confirmed a TP53 mutation, prompting prophylactic bilateral oophorectomy with salpingectomy. In 2021, the patient presented with an erythematous skin lesion in the right axilla, initially resembling a benign spot but later exhibiting concerning features indicative of EMPD. Histopathological examination of the excised lesion confirmed the diagnosis. Immunohistochemistry was positive for CAM5.2 and HER2 and negative for S-100, HMB45, CKHMW, SOX10 and P63 The patient remains free of recurrence at 32 months of follow-up. This case highlights the diagnostic challenges associated with axillary EMPD, emphasizing the importance of careful evaluation and consideration of rare malignancies, particularly in patients with a complex oncological background. The co-occurrence of EMPD with multiple malignancies raises questions about potential underlying genetic predispositions and shared etiological factors, warranting further investigation into the pathogenesis of EMPD and its association with other cancers. Understanding these mechanisms may facilitate improved management strategies for patients with similar clinical profiles.

Article available in PDF format

View PDF Download PDF file

References

  1. Morris CR, Hurst EA. Extramammary Paget Disease: A Review of the Literature-Part I: History, Epidemiology, Pathogenesis, Presentation, Histopathology, and Diagnostic Work-up. Dermatol Surg. 2020; 46(2): 151–158.
  2. Osman S, Tataroglu C, Şavk E. Extramammary Paget's disease: Report of two cases located on the vulva and penis. TURKDERM. 2023: 157–162.
  3. Crocker HR. Paget’s disease affecting the scrotum and penis. Trans Pathol Soc London. 1889; 40: 187–191.
  4. Ishizuki S, Nakamura Y. Extramammary Paget's Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments. Curr Oncol. 2021; 28(4): 2969–2986.
  5. Ren F, Zhao S, Yang C, et al. Applications of photodynamic therapy in extramammary Paget's disease. Am J Cancer Res. 2023; 13(10): 4492–4507.
  6. Kibbi N, Owen JL, Worley B, et al. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease. JAMA Oncol. 2022; 8(4): 618–628.
  7. Zhao C, Li Y, Zhang C, et al. Extramammary Paget’s disease involving the axilla: case series and literature review. Int J Dermatol. 2023; 62(7): 933–937.
  8. Ito T, Kaku-Ito Y, Furue M. The diagnosis and management of extramammary Paget's disease. Expert Rev Anticancer Ther. 2018; 18(6): 543–553.
  9. Osman S, Tataroglu C, Şavk E. Extramammary Paget's disease: Report of two cases located on the vulva and penis. TURKDERM. 2023: 157–162.
  10. Ghazawi FM, Iga N, Tanaka R, et al. Demographic and clinical characteristics of extramammary Paget's disease patients in Japan from 2000 to 2019. J Eur Acad Dermatol Venereol. 2021; 35(2): e133–e135.
  11. Ji WY, Luo B, Wang XW, et al. Axillary Paget disease with a visible satellite: a case report and literature review. Diagn Pathol. 2021; 16(1): 69.
  12. Binesh F, Nokhostin F, Dehshiri F, et al. Extramammary Paget's disease and papillary thyroid carcinoma: two related or unrelated diseases? The Journal of Medical Research. 2023; 9(2): 16–19.
  13. Geers J, Wildiers H, Van Calster K, et al. Oncological safety of autologous breast reconstruction after mastectomy for invasive breast cancer. BMC Cancer. 2018; 18(1): 994.
  14. Dillekås H, Demicheli R, Ardoino I, et al. The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. Breast Cancer Res Treat. 2016; 158(1): 169–178.
  15. Gomatou G, Syrigos N, Vathiotis IA, et al. Tumor Dormancy: Implications for Invasion and Metastasis. Int J Mol Sci. 2021; 22(9).
  16. Svee A, Mani M, Sandquist K, et al. Survival and risk of breast cancer recurrence after breast reconstruction with deep inferior epigastric perforator flap. Br J Surg. 2018; 105(11): 1446–1453.
  17. Maeda T, Yanagi T, Kitamura S, et al. A familial case of extramammary Paget disease: Analysis of whole-exome sequencing. EJC Skin Cancer. 2024; 2: 100025.